drugset / Trial / NCT03565458
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
RandomizedCrossoverOpen-labelTreatment
Summary
gemigliptin,SGLT-2i DDI study
Timeline
- Start
- 2018-04-05
- Primary completion
- 2018-08-20
- Completion
- 2018-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Empagliflozin | Small molecule | 25 mg | Oral |
| Subject | Gemigliptin | Small molecule | 50 mg | Oral |